HMGB1 in inflammation and cancer
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
High mobility group box 1 (HMGB1) is a non-histone chromatin-associated protein widely distributed in eukaryotic cells and is involved in DNA damage repair and genomic stability maintenance. In response to stimulus like bacteria or chemoradiotherapy, HMGB1 can translocate to extracellular context as a danger alarmin, activate the immune response, and participate in the regulation of inflammation and cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Stressed macrophages and mesothelial cells undergo cell necrosis, releasing the damage-associated molecular protein (DAMP) high mobility group box 1 (HMGB1) [20].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437 · cited 1×
“HMGB1 plays a critical role in the regulation of both innate and adaptive immune responses to promote immune response to sterile or infectious stimulus [6].”
BackgroundA New Group of Chromatin‐Associated Proteins with a High Content of Acidic and Basic Amino Acids
Goodwin, G. H., Sanders, C., & Johns, E. W. (1973) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1973.tb03026.x · Cited by 780
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Deng, M., Tang, Y., Li, W., Wang, X., Zhang, R., Zhang, X., Zhao, X., Liu, J., Tang, C., Liu, Z., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.016 · Cited by 591
Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
Liu, Y., Dong, Y., Kong, L., Shi, F., Zhu, H., & Yu, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0647-8 · Cited by 447
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Andersson, U., Ottestad, W., & Tracey, K. J. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00172-4 · Cited by 229
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
Yuan, S., Liu, Z., Xu, Z., Liu, J., & Zhang, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00920-3 · Cited by 226
Gao, Q., Wang, S., Chen, X., Cheng, S., Zhang, Z., Li, F., Huang, L., Yang, Y., Zhou, B., Yue, D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0511-6 · Cited by 215
Self-citationPaudel, Y. N., Angelopoulou, E., Piperi, C., Balasubramaniam, V. R. M. T., Othman, I., & Shaikh, M. F. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172487 · Cited by 174
Pusterla, T., Nèmeth, J., Stein, I., Wiechert, L., Knigin, D., Marhenke, S., Longerich, T., Kumar, V., Arnold, B., Vogel, A., et al. (2013) · Hepatology · doi:10.1002/hep.26395 · Cited by 97
Cited by
Lactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02095-6 · Cited by 317
Hayes, C., Donohoe, C. L., Davern, M., & Donlon, N. E. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.021 · Cited by 213
Mao, Q., Min, J., Zeng, R., Liu, H., Li, H., Zhang, C., Zheng, A., Lin, J., Liu, X., & Wu, M. (2022) · Theranostics · doi:10.7150/thno.72509 · Cited by 133
Zhou, J., Wang, W., Zhang, C.-Y., Ling, Y., Hong, X.-J., Su, Q., Li, W.-G., Mao, Z., Cheng, B., Tan, C., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121757 · Cited by 111
Metadata
- Authors
- Wang, S., & Zhang, Y.
- Affiliations
- Zhengzhou University (CN)
- Corresponding author
- Zhang, Yi
- ORCID
- Zhang, Yi
- Venue
- Journal of Hematology & Oncology
- Published
- 2020-08-24
- Volume
- 13
- Issue
- 1
- Pages
- 116-116
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC7443612
- OpenAlex
- W3080129155
- Cited by
- 294
- References
- 17
- Citations by year
- 2026: 44 · 2025: 65 · 2024: 53 · 2023: 65 · 2022: 50 · 2021: 16 · 2020: 1
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the National Key Research and Development Program of China (2016YFC1303500)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Keywords
- HMGB1, high mobility group box 1, inflammation, tumor progression, extracellular HMGB1, DNA repair, genome stability, immune response, chemoradiotherapy
- MeSH terms
- Autophagy, Cell Nucleus, Cell Survival, Cytoplasm, DNA Repair, Humans, Immunity, Immunotherapy, Inflammation, Neoplasm Proteins, Neoplasms, Cytokines, Apoptosis, HMGB1 Protein, Chemoradiotherapy, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HMGB1 in inflammation and cancer. https://app.cochat.ai/papers/10.1186/s13045-020-00950-x
- The paper
- Wang, S., & Zhang, Y. (2020). HMGB1 in inflammation and cancer. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-020-00950-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.